Functional role and potential therapeutic use of Reelin, Gas6 and Protein S in relation to adult neural stem or progenitor cells

Göran Bertilsson (Inventor), Anna Falk (Inventor), Jonas Frisén (Inventor), Jessica Heidrich (Inventor), Kristina Hellström (Inventor), J Kortesmaa (Inventor), Per Lindquist (Inventor), Hanna Lundh (Inventor), Jacqueline McGuire (Inventor), Alex Mercer (Inventor), Cesare Patrone (Inventor), Harriet Rönnholm (Inventor), Lilian Wikström (Inventor), Olof Zachrisson (Inventor)

Research output: Patent

Abstract

The invention relates generally to methods of influencing central nervous system cells to produce progeny useful in the treatment of CNS disorders. More specifically, the invention includes methods of exposing a patient suffering from such a disorder to a reagent that modulates the proliferation, migration, differentiation and survival of central nervous system cells via PACAP, Maxadilan or VIP signaling. These methods are useful for reducing at least one symptom of the disorder.
Original languageEnglish
Patent numberUS Patent App. 10/291,171, 2003
IPC2003/9/4 US 10291171
Publication statusPublished - 2003
Externally publishedYes

Subject classification (UKÄ)

  • Neurosciences
  • Cell and Molecular Biology

Fingerprint

Dive into the research topics of 'Functional role and potential therapeutic use of Reelin, Gas6 and Protein S in relation to adult neural stem or progenitor cells'. Together they form a unique fingerprint.

Cite this